31604
37927
Navi ELSS Tax Saver Fund - Direct (G)
https://storage.googleapis.com/5paisa-prod-storage/files/2024-10/navi-logo.png
7
1
7
1
3.5
Invest in Mutual Funds at 0 Transaction cost
-
NAV
32.81
10 Apr 2026
-
1.16%
1 Day
Note: Data shown is for Direct Plan. Our Platform offers Regular Plans only.
Returns may differ due to expense ratio differences.
-
₹ 500
Min SIP -
₹ 500
Min Lumpsum -
0.37%
Expense Ratio -
44 Cr
Fund Size -
10 Years
Fund Age
Returns and Ranks ( as on 10 Apr 2026 )
- 1Y Returns
- 3Y Returns
- 5Y Returns
- MAX Returns
- Trailing Returns
- -2.04%
- 19.07%
- 15.86%
- 14.22
- NAAlpha
- NASD
- NABeta
- NASharpe
- Exit Load
- Nil
- Tax implication
- Returns redeemed within a year are taxed at 20%, while those held longer incur a 12.5% LTCG tax on gains over Rs 1.25 lakh per financial year.
The Scheme will seek to invest predominantly in a diversified portfolio of equity and equity related instruments with the objective to provide investors with opportunities for capital appreciation and income generation along with the benefit of income tax deduction (under Section 80 C of the Income Tax Act, 1961) on their investments.
Low
Low to
moderate Moderate Moderately
High High Very
High
moderate Moderate Moderately
High High Very
High
No data available
Other Calculators
FAQs
Navi ELSS Tax Saver Fund - Direct (G) has delivered 15.56% since inception
The NAV of Navi ELSS Tax Saver Fund - Direct (G) is ₹34.3644 as of 10 Apr 2026
The expense ratio of Navi ELSS Tax Saver Fund - Direct (G) is 0.37 % as of 10 Apr 2026
The AUM of Navi ELSS Tax Saver Fund - Direct (G) 61.66 CR as of 10 Apr 2026
The minimum SIP amount of Navi ELSS Tax Saver Fund - Direct (G) is 500
The top stock holdings of Navi ELSS Tax Saver Fund - Direct (G) are
- Reliance Industr - 5.70%
- Axis Bank - 5.18%
- Sun Pharma.Inds. - 4.22%
- Bharti Airtel - 4.08%
- Ashok Leyland - 4.07%
The top sectors Navi ELSS Tax Saver Fund - Direct (G) has invested in are
- Banks - 15.2%
- IT-Software - 10.61%
- Aerospace & Defense - 9.66%
- Cash & Others - 7.27%
- Pharmaceuticals & Biotech - 5.83%